Evidence map›Paper›PMID 34099767›Full record

ArticleScientific reports2021

Aspartate aminotransferase to alanine aminotransferase ratio is associated with frailty and mortality in older patients with heart failure.

Daichi Maeda, Nobuyuki Kagiyama, Kentaro Jujo, Kazuya Saito, Kentaro Kamiya, Hiroshi Saito, Yuki Ogasahara, Emi Maekawa, Masaaki Konishi, Takeshi Kitai and 15 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 14 institutions in 1 country.

Daichi MaedaDepartment of Cardiology, Osaka Medical College, Takatsuki, Japan.
Nobuyuki KagiyamaDepartment of Cardiology, The Sakakibara Heart Institute of Okayama, Okayama, Japan.
Kentaro JujoDepartment of Cardiology, Nishiarai Heart Center Hospital, Tokyo, Japan.
Kazuya SaitoDepartment of Rehabilitation, The Sakakibara Heart Institute of Okayama, Okayama, Japan.
Kentaro KamiyaDepartment of Rehabilitation, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.
Hiroshi SaitoDepartment of Rehabilitation, Kameda Medical Center, Kamogawa, Japan.
Yuki OgasaharaDepartment of Nursing, The Sakakibara Heart Institute of Okayama, Okayama, Japan.
Emi MaekawaDepartment of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
Masaaki KonishiDivision of Cardiology, Yokohama City University Medical Center, Yokohama, Japan.
Takeshi KitaiDepartment of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.
Kentaro IwataDepartment of Rehabilitation, Kobe City Medical Center General Hospital, Kobe, Japan.
Hiroshi WadaDepartment of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Masaru HikiDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Taishi DotareDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Tsutomu SunayamaDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Takatoshi KasaiDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Hirofumi NagamatsuDepartment of Cardiology, Tokai University School of Medicine, Isehara, Japan.
Tetsuya OzawaDepartment of Rehabilitation, Odawara Municipal Hospital, Odawara, Japan.
Katsuya IzawaDepartment of Rehabilitation, Kasukabe Chuo General Hospital, Kasukabe, Japan.
Shuhei YamamotoDepartment of Rehabilitation, Shinshu University Hospital, Matsumoto, Japan.
Naoki AizawaDepartment of Cardiovascular Medicine, Nephrology and Neurology, University of the Ryukyus, Okinawa, Japan.
Ryusuke YonezawaRehabilitation Center, Kitasato University Medical Center, Kitamoto, Japan.
Kazuhiro OkaDepartment of Rehabilitation, Saitama Citizens Medical Center, Saitama, Japan.
Shin-Ichi MomomuraSaitama Citizens Medical Center, Saitama, Japan.
Yuya MatsueDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. yuya8950@gmail.com.
Juntendo University · JPKitasato University · JPKobe City Medical Center General Hospital · JPSakakibara Hospital · JPCitizen (Japan) · JPHiroshima City Asa Citizens Hospital · JPJichi Medical University · JPKitasato University Medical Center · JPOdawara Municipal Hospital · JPOsaka Medical and Pharmaceutical University · JPShinshu University Hospital · JPTokai University · JPUniversity of the Ryukyus · JPYokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Frailty is a common comorbidity associated with adverse events in patients with heart failure, and early recognition is key to improving its management. We hypothesized that the AST to ALT ratio (AAR) could be a marker of frailty in patients with heart failure. Data from the FRAGILE-HF study were analyzed. A total of 1327 patients aged ≥ 65 years hospitalized with heart failure were categorized into three groups based on their AAR at discharge: low AAR (AAR < 1.16, n = 434); middle AAR (1.16 ≤ AAR < 1.70, n = 487); high AAR (AAR ≥ 1.70, n = 406). The primary endpoint was one-year mortality. The association between AAR and physical function was also assessed. High AAR was associated with lower short physical performance battery and shorter 6-min walk distance, and these associations were independent of age and sex. Logistic regression analysis revealed that high AAR was an independent marker of physical frailty after adjustment for age, sex and body mass index. During follow-up, all-cause death occurred in 161 patients. After adjusting for confounding factors, high AAR was associated with all-cause death (low AAR vs. high AAR, hazard ratio: 1.57, 95% confidence interval, 1.02-2.42; P = 0.040). In conclusion, AAR is a marker of frailty and prognostic for all-cause mortality in older patients with heart failure.

Indexed as

AgedAged, 80 and overAlanine TransaminaseAspartate AminotransferasesBiomarkersCause of DeathCohort StudiesFemaleFrailtyHeart FailureHospitalizationHumansKaplan-Meier EstimateLogistic ModelsMalePrognosisAlanine TransaminaseAspartate AminotransferasesBiomarkers

Identifiers

PMID34099767
PMCPMC8184951
OpenAlexW3159545723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.